Go offline with the Player FM app!
Podcasts Worth a Listen
SPONSORED
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy
Manage episode 426573497 series 2891295
Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy.
Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas
Continue this conversation on social!
Follow us today at...
https://bsky.app/profile/lancetgastrohep.bsky.social
https://www.linkedin.com/company/langastro/
https://instagram.com/thelancetgroup
85 episodes
Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy
The Lancet Gastroenterology & Hepatology in conversation with
Manage episode 426573497 series 2891295
Nancy Baxter (University of Melbourne) discusses a population-based study on the duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy.
Read the full article:
https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00084-0?dgcid=buzzsprout_icw_podcast_generic_langas
Continue this conversation on social!
Follow us today at...
https://bsky.app/profile/lancetgastrohep.bsky.social
https://www.linkedin.com/company/langastro/
https://instagram.com/thelancetgroup
85 episodes
Alla avsnitt
×
1 John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer 13:29

1 Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes 21:23

1 Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures 11:15

1 Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis 14:42

1 Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease 34:15

1 Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer 18:23

1 Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy 25:05

1 Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS 23:16

1 Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease 19:55

1 Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa 20:54

1 Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake 16:39

1 Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity 23:19

1 Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region 14:40

1 Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy 14:45

1 Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease 16:19
Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.